Overview
Annette Lasham practices practicing medicine in Auckland, New Zealand.
Her clinical expertise encompasses Mesothelioma, Breast Cancer, Triple-Negative Breast Cancer, and Lung Cancer.
She is actively involved in clinical research, co-authoring 25 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Annette Lasham
Is Annette Lasham a top-rated expert for Mesothelioma?
MediFind is an objective health platform that identifies experts based on real-world data. Annette Lasham is classified as an Experienced expert for Mesothelioma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Annette Lasham participate in research or clinical trials?
Yes. Annette Lasham has published 25 articles and abstracts on conditions like Mesothelioma. You can view a list of Annette Lasham's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Breast CancerMs. Lasham isExperienced. Learn about Breast Cancer.
- Lung CancerMs. Lasham isExperienced. Learn about Lung Cancer.
- MesotheliomaMs. Lasham isExperienced. Learn about Mesothelioma.
- Triple-Negative Breast CancerMs. Lasham isExperienced. Learn about Triple-Negative Breast Cancer.